Skip to main content Skip to main navigation menu Skip to site footer
CUAJ|JUAC
  • Home
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Issues
  • Guidelines
  • Supplements & Abstracts
  • CPD Credits
  • Journal Club
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Vol. 10 No. 11-12 (2016): CUAJ December Suppl 7

Vol. 10 No. 11-12 (2016): CUAJ December Suppl 7

Published: 2016-12-15

Supplement-Introduction

  • Sunitinib: 10 years of clinical experience in the treatment of advanced renal cell carcinoma
    Anil Kapoor
    S235
    • PDF

Supplement-Review

  • First-line treatment options in metastatic renal cell cancer
    Anil Kapoor
    S236-8
    • PDF
  • Practical first-line management of renal cell carcinoma in a community practice
    Henry Conter
    S239-41
    • PDF
  • Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Naveen S. Basappa
    S242-4
    • PDF
  • Sunitinib side effects as surrogate biomarkers of efficacy
    Christian Kollmannsberger
    S245-7
    • PDF
  • Sunitinib toxicity management – a practical approach
    Sandeep Sehdev
    S248-51
    • PDF
  • Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?
    Georg A. Bjarnason
    S252-5
    • PDF
  • The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma
    Daniel Y.C. Heng
    S256-8
    • PDF
Most read last week
  • Comprehensive assessment of the morbidity of renal mass biopsy: A population-based assessment of biopsy-related complications
    104
  • Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update
    58
  • Refusal of surgery: A case-based review of ethical and legal principles behind informed consent in Canada
    46
  • Canadian Urological Association clinical practice guideline on testosterone deficiency in men: Evidence-based Q&A
    37
  • Canadian guidelines for the management of asymptomatic microscopic hematuria in adults
    30



For advertising information, click here


JOB POSTINGS

New! 

Locum (Part-Time or Full-Time)
Barrie, Ontario

 


McMaster Institute of Urology at St. Joseph’s Healthcare
Advanced Laparoscopic/Robotic and Endourology Fellowship



vesia/Southern Alberta
Institute of Urology/University of Calgary
Fellowship in reconstructive & functional urology

COVID-19-RELATED ARTICLES:

Mitigating effects of a second wave of COVID-19

Early adaptation of urology residency educational programs during COVID-19 restrictions

Male genitalia injuries during COVID-19

Pediatric urological surgery readiness condition (PedsUROCON)

Managing prostate cancer during COVID-19

Prioritizing/managing pediatric urology conditions during COVID-19

Impact of COVID-19 on Canadian urology residents 

Urology education in the time of COVID-19

Patient-urologist relationship in COVID-19 era and beyond

Impact of COVID-19 on CaRMS

Managing men’s health conditions during COVID-19 

Prioritizing systemic therapies for GU malignancies during COVID-19

How to prioritize urological surgeries during epidemics

 

 

Obtain CPD Credit! CUAJ now provides readers with Section 3 credits of the Maintenance of Certification (self-assessment) program with the RCPSC. Read the latest accredited article, answer the multiple-choice questionnaire, and log the self-learning activity in your Royal College MAINPORT account.

 

 

 
Language
  • English
  • Français (Canada)

Canadian Urological Association Journal eISSN 1920-1214 | Published by the Canadian Urological Association, 185 Dorval Avenue, Dorval, QC, Canada, H9S 5J9
T. 514-395-0376 | F. 514-395-1664
Contact | Privacy Policy | Follow @CanUrolAssoc

About this Publishing System